Fructosamine in non-diabetic first degree relatives of type 2 diabetes patients: Risk assessor

Poornima Ajay Manjrekar, Anupama Hegde, Shrilaxmi, Fiona D'souza, Vishwas Kaveeshwar, Anupama Jose, Sana Tasneem, Ramya Shenoy

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Introduction: A positive family history of diabetes increases the chances of developing the disease manifold. The earliest diagnostic marker for diabetes is elevated plasma glucose levels. Glycosylated haemoglobin (HbA1c) gives information on the long term control of diabetes, while the estimation of fructosamine (FA) depicts the short term glycaemic control. The specificity of the estimation of fructosamine and its comparison with the established markers in a group with high risk for the disease was the purport. Methods: 23 non-diabetic first degree relatives of type 2 diabetics (Group 2) were compared with 20 healthy controls (Group 1) and 23 type 2 diabetic people (Group 3). Fasting plasma glucose (FPG), glycosylated haemoglobin (HbA1c), serum fructosamine and total proteins (TP) were estimated in fasting blood samples. The saliva was analyzed for fasting salivary glucose (SG), salivary fructosamine and total proteins. The body mass index (BMI), waist circumference (WC) and the blood pressure were recorded and compared. Results: Group 3 had significantly higher mean FPG (150.26mg/dl), HbA1c (8.23 %) and salivary FA (202.05 mg/dl) values. Group 2 was associated with elevated serum FA levels (533.62 mg/dl), increased serum FA/ total protein (TP) ratio and a larger WC. On correlation analysis, FPG correlated significantly and positively with HbA1c in all three groups and with WC and BMI (0.613 and 0.400 respectively) in Group 2 only. Conclusion: Serum FA foretells the development of diabetes in high risk populations, but it has less sensitivity in depicting chronic hyperglycaemia. Serum FA and WC could be useful predictors of the development of diabetes in 'high risk' individuals.

Original languageEnglish
Pages (from-to)770-773
Number of pages4
JournalJournal of Clinical and Diagnostic Research
Volume6
Issue number5
Publication statusPublished - 22-06-2012

Fingerprint

Fructosamine
Medical problems
Type 2 Diabetes Mellitus
Waist Circumference
Fasting
Glucose
Plasmas
Serum
Glycosylated Hemoglobin A
Body Mass Index
Proteins
Blood pressure
Saliva
Hyperglycemia
Blood
Blood Pressure

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry

Cite this

@article{9c4854c33433429a98c83f17849ff4b5,
title = "Fructosamine in non-diabetic first degree relatives of type 2 diabetes patients: Risk assessor",
abstract = "Introduction: A positive family history of diabetes increases the chances of developing the disease manifold. The earliest diagnostic marker for diabetes is elevated plasma glucose levels. Glycosylated haemoglobin (HbA1c) gives information on the long term control of diabetes, while the estimation of fructosamine (FA) depicts the short term glycaemic control. The specificity of the estimation of fructosamine and its comparison with the established markers in a group with high risk for the disease was the purport. Methods: 23 non-diabetic first degree relatives of type 2 diabetics (Group 2) were compared with 20 healthy controls (Group 1) and 23 type 2 diabetic people (Group 3). Fasting plasma glucose (FPG), glycosylated haemoglobin (HbA1c), serum fructosamine and total proteins (TP) were estimated in fasting blood samples. The saliva was analyzed for fasting salivary glucose (SG), salivary fructosamine and total proteins. The body mass index (BMI), waist circumference (WC) and the blood pressure were recorded and compared. Results: Group 3 had significantly higher mean FPG (150.26mg/dl), HbA1c (8.23 {\%}) and salivary FA (202.05 mg/dl) values. Group 2 was associated with elevated serum FA levels (533.62 mg/dl), increased serum FA/ total protein (TP) ratio and a larger WC. On correlation analysis, FPG correlated significantly and positively with HbA1c in all three groups and with WC and BMI (0.613 and 0.400 respectively) in Group 2 only. Conclusion: Serum FA foretells the development of diabetes in high risk populations, but it has less sensitivity in depicting chronic hyperglycaemia. Serum FA and WC could be useful predictors of the development of diabetes in 'high risk' individuals.",
author = "Manjrekar, {Poornima Ajay} and Anupama Hegde and Shrilaxmi and Fiona D'souza and Vishwas Kaveeshwar and Anupama Jose and Sana Tasneem and Ramya Shenoy",
year = "2012",
month = "6",
day = "22",
language = "English",
volume = "6",
pages = "770--773",
journal = "Journal of Clinical and Diagnostic Research",
issn = "2249-782X",
publisher = "Journal of Clinical and Diagnostic Research",
number = "5",

}

Fructosamine in non-diabetic first degree relatives of type 2 diabetes patients : Risk assessor. / Manjrekar, Poornima Ajay; Hegde, Anupama; Shrilaxmi; D'souza, Fiona; Kaveeshwar, Vishwas; Jose, Anupama; Tasneem, Sana; Shenoy, Ramya.

In: Journal of Clinical and Diagnostic Research, Vol. 6, No. 5, 22.06.2012, p. 770-773.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Fructosamine in non-diabetic first degree relatives of type 2 diabetes patients

T2 - Risk assessor

AU - Manjrekar, Poornima Ajay

AU - Hegde, Anupama

AU - Shrilaxmi,

AU - D'souza, Fiona

AU - Kaveeshwar, Vishwas

AU - Jose, Anupama

AU - Tasneem, Sana

AU - Shenoy, Ramya

PY - 2012/6/22

Y1 - 2012/6/22

N2 - Introduction: A positive family history of diabetes increases the chances of developing the disease manifold. The earliest diagnostic marker for diabetes is elevated plasma glucose levels. Glycosylated haemoglobin (HbA1c) gives information on the long term control of diabetes, while the estimation of fructosamine (FA) depicts the short term glycaemic control. The specificity of the estimation of fructosamine and its comparison with the established markers in a group with high risk for the disease was the purport. Methods: 23 non-diabetic first degree relatives of type 2 diabetics (Group 2) were compared with 20 healthy controls (Group 1) and 23 type 2 diabetic people (Group 3). Fasting plasma glucose (FPG), glycosylated haemoglobin (HbA1c), serum fructosamine and total proteins (TP) were estimated in fasting blood samples. The saliva was analyzed for fasting salivary glucose (SG), salivary fructosamine and total proteins. The body mass index (BMI), waist circumference (WC) and the blood pressure were recorded and compared. Results: Group 3 had significantly higher mean FPG (150.26mg/dl), HbA1c (8.23 %) and salivary FA (202.05 mg/dl) values. Group 2 was associated with elevated serum FA levels (533.62 mg/dl), increased serum FA/ total protein (TP) ratio and a larger WC. On correlation analysis, FPG correlated significantly and positively with HbA1c in all three groups and with WC and BMI (0.613 and 0.400 respectively) in Group 2 only. Conclusion: Serum FA foretells the development of diabetes in high risk populations, but it has less sensitivity in depicting chronic hyperglycaemia. Serum FA and WC could be useful predictors of the development of diabetes in 'high risk' individuals.

AB - Introduction: A positive family history of diabetes increases the chances of developing the disease manifold. The earliest diagnostic marker for diabetes is elevated plasma glucose levels. Glycosylated haemoglobin (HbA1c) gives information on the long term control of diabetes, while the estimation of fructosamine (FA) depicts the short term glycaemic control. The specificity of the estimation of fructosamine and its comparison with the established markers in a group with high risk for the disease was the purport. Methods: 23 non-diabetic first degree relatives of type 2 diabetics (Group 2) were compared with 20 healthy controls (Group 1) and 23 type 2 diabetic people (Group 3). Fasting plasma glucose (FPG), glycosylated haemoglobin (HbA1c), serum fructosamine and total proteins (TP) were estimated in fasting blood samples. The saliva was analyzed for fasting salivary glucose (SG), salivary fructosamine and total proteins. The body mass index (BMI), waist circumference (WC) and the blood pressure were recorded and compared. Results: Group 3 had significantly higher mean FPG (150.26mg/dl), HbA1c (8.23 %) and salivary FA (202.05 mg/dl) values. Group 2 was associated with elevated serum FA levels (533.62 mg/dl), increased serum FA/ total protein (TP) ratio and a larger WC. On correlation analysis, FPG correlated significantly and positively with HbA1c in all three groups and with WC and BMI (0.613 and 0.400 respectively) in Group 2 only. Conclusion: Serum FA foretells the development of diabetes in high risk populations, but it has less sensitivity in depicting chronic hyperglycaemia. Serum FA and WC could be useful predictors of the development of diabetes in 'high risk' individuals.

UR - http://www.scopus.com/inward/record.url?scp=84866045173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866045173&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84866045173

VL - 6

SP - 770

EP - 773

JO - Journal of Clinical and Diagnostic Research

JF - Journal of Clinical and Diagnostic Research

SN - 2249-782X

IS - 5

ER -